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Introduction: Liberal and overaggressive use of vasopressors during the initial period of shock resuscitation may
compromise organ perfusion and worsen outcome. When transiently applying the concept of permissive
hypotension, it would be helpful to know at which arterial blood pressure terminal cardiovascular collapse occurs.
Methods: In this retrospective cohort study, we aimed to identify the arterial blood pressure associated with
terminal cardiovascular collapse in 140 patients who died in the intensive care unit while being invasively
monitored. Demographic data, co-morbid conditions and clinical data at admission and during the 24 hours before
and at the time of terminal cardiovascular collapse were collected. The systolic, mean and diastolic arterial blood
pressures immediately before terminal cardiovascular collapse were documented. Terminal cardiovascular collapse
was defined as an abrupt (<5 minutes) and exponential decrease in heart rate (>50% compared to preceding
values) followed by cardiac arrest.
Results: The mean ± standard deviation (SD) values of the systolic, mean and diastolic arterial blood pressures associated
with terminal cardiovascular collapse were 47 ± 12 mmHg, 35 ± 11 mmHg and 29 ± 9 mmHg, respectively. Patients with
congestive heart failure (39 ± 13 mmHg versus 34 ± 10 mmHg; P = 0.04), left main stem stenosis (39 ± 11 mmHg versus
34 ± 11 mmHg; P = 0.03) or acute right heart failure (39 ± 13 mmHg versus 34 ± 10 mmHg; P = 0.03) had higher arterial
blood pressures than patients without these risk factors. Patients with severe valvular aortic stenosis had the highest
arterial blood pressures associated with terminal cardiovascular collapse (systolic, 60 ± 20 mmHg; mean, 46 ± 12 mmHg;
diastolic, 36 ± 10 mmHg), but this difference was not significant. Patients with sepsis and patients exposed to sedatives or
opioids during the terminal phase exhibited lower arterial blood pressures than patients without sepsis or administration
of such drugs.
Conclusions: The arterial blood pressure associated with terminal cardiovascular collapse in critically ill patients was very
low and varied with individual co-morbid conditions (for example, congestive heart failure, left main stem stenosis, severe
valvular aortic stenosis, acute right heart failure), drug exposure (for example, sedatives or opioids) and the type of acute
illness (for example, sepsis).Introduction
In patients with shock, it is imperative to reestablish ad-
equate systemic blood flow and reverse tissue hypoperfusion
[1]. This can typically be achieved by the administration of
fluids and/or inotropes [1,2]. In severe arterial hypotension,
however, the treatment response to these interventions may* Correspondence: m.duenser@salk.at
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unless otherwise stated.be too slow to rapidly increase arterial blood pressure levels
to currently recommended levels (for example, a mean ar-
terial blood pressure ≥65 mmHg [3,4]), despite reversal of
the underlying pathology (for example, replenishment of
hypovolemia, inotropic therapy). This is the reason why
vasopressor drugs, such as norepinephrine, are commonly
started liberally to avoid cardiovascular collapse due to on-
going arterial hypotension. Recent data, however, suggest
that liberal use of vasoactive agents during the first hour
may adversely affect mortality due to shock [5], particularly
when systemic hypoperfusion is present, such as duringal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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restrictive vasopressor therapy during the first hours of
shock can lead to improved tissue perfusion and less organ
dysfunction, putatively by avoiding vasopressor-induced ag-
gravation of systemic vasoconstriction and aggravation of
tissue hypoperfusion [7]. Even marked delays in initiation of
vasopressor therapy were associated with only a small in-
crease in the risk of death in 8,640 patients with septic shock
[8]. Because a strategy of restrictive vasopressor use during
the early phase of shock implies that a certain degree of ar-
terial hypotension is transiently tolerated to buy time so that
definite hemorrhage control can be achieved (for example,
in traumatic-hemorrhagic shock) [9] or ongoing fluid resus-
citation and inotropic therapy can restore systemic blood
flow (for example, in septic shock) [10]. When implement-
ing such a concept of permissive hypotension with a primary
focus on reversal of systemic hypoperfusion during early
shock resuscitation, it would be helpful to know the range
of arterial hypotension levels within which cardiovascular
collapse occurs. Identification of these levels of arterial blood
pressure, together with a certain safety margin, could help
to guide emergent use of vasopressor drugs and avoid over-
aggressive use of vasoconstrictors in patients with systemic
hypoperfusion [10,11].
In this retrospective cohort study, we aimed to identify
the arterial blood pressure associated with terminal car-
diovascular collapse in 140 patients who died in the inten-
sive care unit (ICU) while being invasively monitored.
Materials and methods
This study was designed as a retrospective cohort ana-
lysis. It included patients admitted to a 37-bed medical-
surgical ICU of a tertiary university teaching hospital
between July 2011 and April 2013. The study protocol
was evaluated by the local ethics committee (Ethikkomission
für das Bundesland Salzburg; 415-EP/73/203-2013), which
waived the requirement for written informed consent be-
cause of the retrospective study design.
Study patients and data collection
All critically ill patients who were invasively monitored
and died in the ICU during the observation period were
eligible for enrollment. The exclusion criteria were age
younger than 18 years, pregnancy, organ donation fol-
lowing brain(stem) death, immediate death after with-
drawal of ventricular assist device support and absence
of continuous electrocardiographic or invasive arterial
blood pressure measurements.
All study variables were extracted from the institutional
electronic patient data management system (MetaVision;
IMDSoft, Tel Aviv, Israel). This system prospectively
collects demographic data and patient characteristics;
hemodynamic and other vital parameters are collected
at one minute intervals. The system uses medianfiltering at 1-minute intervals, which is an effective
nonlinear, digital filtering process to eliminate artefacts
due to a signal [12]. Data regarding drugs and fluids
administered are entered manually into the database.
The following study variables were extracted from the
database: age, sex, body mass index, premorbid condi-
tions (known at ICU admission and/or diagnosed at aut-
opsy), admission diagnosis, Simplified Acute Physiology
Score (SAPS) II [13] and SAPS III [14] scores, end-of-life
decisions, time from terminal cardiovascular collapse until
death, cause of death, length of ICU stay and (wherever
available) autopsy results. During the 24 hours before the
terminal cardiovascular collapse, we documented the
Sequential Organ Failure Assessment (SOFA) score [15],
serum creatine kinase MB levels, as well as the presence
and focus of sepsis [16], acute right heart failure (defined
as low cardiac output due to increased pulmonary arterial
pressure or decreased right ventricular contractility diag-
nosed by echocardiography or pulmonary artery catheter
measurements) or shock (defined as need for catechol-
amine infusions to maintain tissue perfusion). At the time
of the terminal cardiovascular collapse (see definition below),
we collected the data for plethysmographic oxygen satur-
ation; body temperature; heart rate; systolic, mean and dia-
stolic arterial blood pressures (zeroing at the midchest
level); central venous pressure; doses of catecholamines,
vasopressin and/or levosimendan; exposure to sedative
drugs and/or opioids; and last measurements of arter-
ial lactate, base deficit, hemoglobin and partial arterial
carbon dioxide tension.
Determination of the arterial blood pressure associated
with terminal cardiovascular collapse
The arterial blood pressure associated with terminal car-
diovascular collapse was defined as the systolic, mean
and diastolic arterial blood pressures immediately (within
1 minute) before terminal cardiovascular collapse oc-
curred. Terminal cardiovascular collapse was defined
as an abrupt (<5 minutes) and exponential decrease in
heart rate (>50% compared to preceding values) followed
by cardiac arrest (Figure 1). Patients in whom the drop in
heart rate preceded the fall in arterial blood pressure were
considered to have rhythmologic pathologies and were ex-
cluded from the analysis.
Study endpoints
The primary endpoint of the study was to identify the
systolic, mean and diastolic arterial blood pressure levels
associated with terminal cardiovascular collapse in this
study population. Secondary endpoints were to deter-
mine and compare these arterial blood pressure levels
within and between the following subgroups: age >65 years,
age >75 years, cardiac surgery, chronic arterial hyperten-
sion, congestive heart failure, coronary artery disease,
Figure 1 Examples of the systolic, mean and diastolic arterial blood pressures at which terminal cardiovascular collapse occurred.
The arterial blood pressure (red curves) at which terminal cardiovascular collapse occurred is indicated by the black arrow), and abrupt and
exponential decrease in heart rate (green curves) is indicated by the white arrow. bpm, Beats per minute.
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peripheral arterial occlusive disease, severe valvular
aortic stenosis (grade 3 or 4), acute right heart failure,
sepsis and shock. In addition, we analyzed whether the
arterial blood pressure at terminal cardiovascular collapse
was correlated with any of the following simultaneously
measured variables: age, SOFA score, hemoglobin, partial
arterial carbon dioxide tension, plethysmographic oxygen
saturation, body temperature and exposition to sedative
drugs and/or opioids.
Statistical analysis
All statistical analyses were performed using the PASW
Statistics 18 software package (SPSS, Chicago, IL, USA).
Following plausibility testing of the dataset, the normality
distribution was checked by using the Kolmogorov-Smirnov
test and was approximately fulfilled by all variables. Descrip-
tive methods were used to present patient characteristics
and the arterial blood pressures associated with terminal
cardiovascular collapse in the study population and sub-
groups. The unpaired Student’s t-test was used to compare
these arterial blood pressure levels between subgroups.Bivariate correlations calculated by applying the Pear-
son correlation coefficient were used to evaluate the
relationship between the arterial blood pressure associ-
ated with terminal cardiovascular collapse and prede-
fined cofactors. P-values <0.05 were considered to indicate
statistical significance. All parameters are presented as
mean values ± SD, if not indicated otherwise.
Results
Two hundred thirteen ICU patients died during the obser-
vation period. Of these, no one was aged <18 years or
pregnant, but electrocardiographic or invasive blood pres-
sure measurements were not recorded in 22 patients. Nine
patients died after organ donation following brain(stem)
death, and five died after withdrawal of venoarterial
extracorporeal membrane oxygenation therapy. Of the
remaining 177 patients, 27 had rhythmological path-
ologies in the terminal phase. In ten patients, the arterial
blood pressure at terminal cardiovascular collapse could
not be determined. Following exclusion of these patients,
140 patients were included in the final analysis (Tables 1
and 2). In 120 patients (85.7%), end-of-life decisions were
Table 1 Characteristics of the study population
Characteristics Patient data (N = 140)
Age (yr) 72.8 ± 13.2
Male sex (n (%)) 87 (62.1)
Body mass index (kg/m2) 26.1 ± 5.5
Comorbid conditions (n (%))
Chronic arterial hypertension 78 (55.7)
Coronary artery disease 57 (40.7)
Congestive heart failure 27 (19.3)
Severe aortic stenosis 3 (2.1)
Chronic renal failure 26 (18.6)
Diabetes mellitus 26 (18.6)
Peripheral arterial occlusive disease 15 (10.7)
Admission diagnosis (n (%))
Post–cardiac arrest 26 (18.6)
Shock of any origin 22 (15.7)
Abdominal disease 21 (15)
Respiratory insufficiency 20 (14.3)
Trauma 12 (8.6)
Post–cardiac surgery 10 (7.1)
Gastrointestinal hemorrhage 7 (5)
Miscellaneous 22 (15.6)
SAPS IIa (points) 53 ± 20
SAPS IIIa (points) 73 ± 18
Intensive care unit length of stay (days) 7.1 ± 9.6
Autopsy performed (n (%)) 84 (60)
aSAPS, Simplified Acute Physiology Score. Data are presented as mean values
± SD, if not otherwise indicated.
Table 2 Clinical data 24 hours before and at the time of
terminal cardiovascular collapse, as well as causes of
death
Clinical data
24 hours before terminal cardiovascular collapse
Sepsis (n (%)) 34 (24.3)
Sepsis focus (n (%))
Abdomen 9 (6.4)
Soft tissue/joints 7 (5)
Lungs 3 (2.1)
Primary bacteremia 2 (1.4)
Miscellaneous 18 (9.3)
Shock (n (%)) 87 (62.1)
Acute right heart failure (n (%)) 22 (15.7)
Sequential Organ Failure Assessment score (points) 12 ± 4
At the time of terminal cardiovascular collapse
Base deficit (mmol/L) −5.1 ± 8
Arterial lactate (mmol/L) 5.4 ± 4.8
Hemoglobin (mg/dl) 9.6 ± 1.9
Partial arterial carbon dioxide tension (mmHg) 52 ± 30
Plethysmographic oxygen saturation (%) 77 ± 16
Body temperature (°C) 36.9 ± 1.8
Heart rate (beats/min) 88 ± 24
Central venous pressure (mmHg) 14 ± 7
Catecholamine infusion (n (%)) 84 (60)
Vasopressin infusion (n (%)) 6 (4.3)
Levosimendan infusion (n (%)) 5 (3.6)
Cause of death
Cardiovascular failure (n (%)) 84 (60)
Multiple organ dysfunction (n (%)) 29 (20.7)
Respiratory failure (n (%)) 15 (10.7)
Severe ischemic encephalopathy (n (%)) 12 (8.6)
Data are presented as mean values ± SD, if not otherwise indicated.
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the time of terminal cardiovascular collapse, 113 patients
(80.7%) were receiving sedatives, opioids or both.
The intraobserver and interobserver agreement for
identification of the arterial blood pressure associated
with terminal cardiovascular collapse were 94% and 88%,
respectively. The systolic, mean and diastolic arterial
blood pressures (mean ± SD) associated with terminal car-
diovascular collapse were 47 ± 12 mmHg, 35 ± 11 mmHg
and 29 ± 9 mmHg, respectively (Table 3). The time from
cardiovascular collapse to death was 31 ± 30 minutes. Pa-
tients with congestive heart failure, left main stem stenosis
or acute right heart failure had higher mean arterial blood
pressures at terminal cardiovascular collapse than patients
without these risk factors. Among the patients with con-
gestive heart failure, 77.8% had coronary artery disease
and 44.4% had left main stem stenosis. Patients with se-
vere valvular aortic stenosis had the highest arterial blood
pressure at terminal cardiovascular collapse, but this dif-
ference missed the significance level (Table 3, Figure 2).
Patients with sepsis during the 24 hours before terminalcardiovascular collapse exhibited lower arterial blood
pressure at terminal cardiovascular collapse than patients
without sepsis. The incidences of comorbid conditions
(congestive heart failure, 8.8% versus 22.6%, P = 0.09; left
main stem stenosis, 8.8% versus 18.9%, P = 0.2; severe
valvular aortic stenosis, 2.9% versus 1.9%, P = 0.57) and
acute right heart failure (17.6% versus 15.1%, P = 0.79), as
well as exposition to sedatives and/or opioids during the
terminal phase (88.2% versus 78.3%, P = 0.32), did not dif-
fer between patients with sepsis and those without sepsis.
No differences in arterial blood pressure at terminal car-
diovascular collapse between the remaining subgroups
were observed (Table 3).
Patients exposed to sedatives and/or opioids at the
time of terminal cardiovascular collapse had lower
Table 3 Arterial blood pressures at terminal cardiovascular collapse
Systolic arterial blood pressure Mean arterial blood pressure Diastolic arterial blood pressure
(Total population, 47 ± 17) (Total population, 35 ± 11) (Total population, 29 ± 9)
Pre-defined risk factors Risk factor No risk factor P-value Risk factor No risk factor P-value Risk factor No risk factor P-value
Age >65 yr (n = 103) 47 ± 17 47 ± 18 0.99 35 ± 11 34 ± 12 0.64 29 ± 9 28 ± 10 0.61
Age >75 yr (n = 66) 50 ± 17 45 ± 17 0.06 37 ± 10 33 ± 11 0.05 30 ± 9 28 ± 10 0.16
Cardiac surgery (n = 10) 51 ± 19 47 ± 17 0.53 35 ± 12 35 ± 11 0.95 27 ± 11 29 ± 9 0.69
Chronic arterial hypertension
(n = 78)
49 ± 17 45 ± 17 0.12 36 ± 11 33 ± 10 0.18 29 ± 10 28 ± 9 0.29
Congestive heart failure (n = 27) 53 ± 20 46 ± 16 0.06 39 ± 13 34 ± 10 0.04a 31 ± 12 28 ± 8 0.17
Coronary artery disease (n = 57) 48 ± 18 47 ± 17 0.76 36 ± 12 34 ± 10 0.34 30 ± 10 28 ± 8 0.27
Diabetes mellitus (n = 26) 47 ± 17 48 ± 17 0.81 35 ± 11 35 ± 11 0.98 29 ± 9 28 ± 9 0.71
Left main stem stenosis (n = 23) 53 ± 16 46 ± 17 0.08 39 ± 11 34 ± 11 0.03a 32 ± 10 28 ± 9 0.07
PAODb (n = 15) 43 ± 17 48 ± 17 0.34 33 ± 10 35 ± 11 0.63 27 ± 8 29 ± 9 0.62
Acute right heart failure (n = 22) 53 ± 20 46 ± 16 0.1 39 ± 13 34 ± 10 0.03a 32 ± 11 28 ± 9 0.06
Sepsis (n = 34) 42 ± 12 49 ± 18 0.005a 30 ± 8 36 ± 11 0.001a 25 ± 8 30 ± 9 0.02a
Severe aortic stenosis (n = 3) 60 ± 20 47 ± 17 0.2 46 ± 12 34 ± 11 0.08 36 ± 10 28 ± 9 0.16
Shock (n = 87) 48 ± 17 47 ± 17 0.73 35 ± 11 34 ± 10 0.36 29 ± 10 27 ± 8 0.14
aSignificant difference. bPAOD, Peripheral arterial occlusive disease. All units are millimeters of mercury. Data are presented as mean values ± SD, if not
indicated otherwise.
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and mean arterial blood pressures (34 ± 11 mmHg versus
39 ± 10 mmHg; P = 0.03) than patients without sedative
and/or opioid administration. The correlation analysis re-
vealed a significant indirect relationship (Table 4). No sig-
nificant correlation was observed between the arterial
blood pressure at terminal cardiovascular collapse and
other cofactors investigated (Table 4). There were also no
relationships between the serum creatine kinase MB and
arterial lactate levels during the last 24 hours with the
mean arterial blood pressure at laboratory measurement
or the arterial blood pressure at terminal cardiovascular
collapse (Additional file 1: Figure S1).
Discussion
In this retrospective cohort study including 140 critically
ill patients, the mean systolic, mean and diastolic arterial
blood pressures associated with terminal cardiovascular
collapse were 47, 35 and 29 mmHg, respectively. Pa-
tients with congestive heart failure, left main stem sten-
osis, acute right heart failure or severe valvular aortic
stenosis exhibited higher arterial blood pressures at ter-
minal cardiovascular collapse than patients without these
risk factors. Patients with sepsis had lower arterial blood
pressures than patients without sepsis. Similarly, systolic
and mean arterial blood pressures were lower in patients
exposed to sedatives and/or opioids at the time of ter-
minal cardiovascular collapse.
In our analysis, we identified the arterial blood pres-
sure associated with terminal cardiovascular collapse as
indicated by an abrupt and exponential drop in heartrate. It is conceivable that, at these low arterial blood
pressure levels, coronary perfusion was reduced to such
an extent that global myocardial hypoperfusion and is-
chemia occurred. As we did not measure coronary blood
flow in our population, no association between the arter-
ial blood pressure at terminal cardiovascular collapse
and the lower threshold of coronary autoregulation can
be made. From a physiologic perspective, it is likely that
terminal cardiovascular collapse occurs at arterial blood
pressures well below the lower coronary autoregulation
limit and that adverse events such as coronary or end-
organ hypoperfusion occur at higher arterial blood pres-
sures than the ones identified in this study [17]. Therefore,
the arterial blood pressures associated with terminal car-
diovascular collapse should by no means implicate safe
values or be regarded as a resuscitation endpoint. They
should instead be considered as the lowest end of cardio-
vascular regulation in a mixed critically ill patient popu-
lation. Even when transiently applying the strategy of
permissive hypotension, these arterial blood pressure
levels should never be reached or tolerated, but rather an
individual safety limit (for example, one or two standard
deviations) above these arterial blood pressure levels
should be maintained.
Five subgroups presented with arterial blood pressures
at terminal cardiovascular collapse that were different
from those in the remaining population. The respective
mean arterial blood pressure levels differed by approxi-
mately 5 mmHg between patients with and those with-
out acute right heart failure. This finding is in line with
clinical observations that patients with acute right heart
Table 4 Bivariate correlations between arterial blood pressures at terminal cardiovascular collapse and predefined
cofactorsa
Cofactor Systolic arterial blood pressure Mean arterial blood pressure Diastolic arterial blood pressure
Pearson coefficient P-value Pearson coefficient P-value Pearson coefficient P-value
Age (yr) 0.1 0.24 0.11 0.2 0.07 0.38
SpO2 (%) −0.06 0.54 0.02 0.82 0.05 0.63
Temperature (°C) −0.08 0.41 −0.09 0.31 −0.13 0.17
Hemoglobin (g/dl) 0.03 0.69 0.04 0.69 <0.01 0.99
PaCO2 (mmHg) 0.15 0.08 0.08 0.38 0.03 0.7
SOFA score (points) −0.04 0.61 0.06 0.48 0.14 0.11
Sedative and/or opioid exposure −0.17 0.048b −0.185 0.03b −0.16 0.06
aPaCO2, partial carbon dioxide pressure; SOFA, Sequential Organ Failure Assessment; SpO2, plethysmographic oxygen saturation.
bSignificant correlation.
Figure 2 Box plots showing arterial blood pressures associated with terminal cardiovascular collapse in patients with and without
specific risk factors. AS, Arterial stenosis; CAD, Coronary artery disease; DAP, Diastolic arterial pressure; HF, Heart failure; MAP, Mean arterial
pressure; RHF, Right heart failure; SAP, Systolic arterial pressure. Boxed areas indicate median values with interquartile ranges. Error bars indicate
minimum and maximum values. The dashed lines represents median values in patients with no risk factor.
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right ventricular function [18,19]. Patients with congestive
heart failure and left main stem stenosis exhibited mean
arterial blood pressures at terminal cardiovascular collapse
that were, on average, 3 to 7 mmHg above those of pa-
tients without these risk factors. As three-fourths of
patients with congestive heart failure had coronary ar-
tery disease and one-half of them from left main stem
stenosis or an equivalent, the two subgroups are likely
to share similar reasons for higher arterial pressure re-
quirements. Higher arterial blood pressures are similarly
required to maintain coronary blood flow in patients with
significant coronary stenosis [20,21]. Although patients
with severe valvular aortic stenosis exhibited the highest
arterial blood pressures at terminal cardiovascular collapse
in this cohort, comparisons with the remaining population
failed to reach the significance level, owing to the small
number of patients (n = 3). Also, in severe aortic stenosis,
arterial blood pressure is a key determinant of coronary
perfusion [22,23], which explains why these patients re-
quired arterial blood pressures 8 to 13 mmHg higher than
patients without severe aortic stenosis. Patients with sepsis
experienced terminal cardiovascular collapse only when
arterial blood pressures were 5 to 7 mmHg lower than in
the remaining population. This observation is striking and
cannot be explained by differences in comorbid conditions
or the incidence of acute right heart failure in these pa-
tients. It may be hypothesized that one reason for this ob-
servation is that sepsis patients had higher cardiac output
levels than patients without sepsis and could thus tolerate
lower arterial blood pressures. However, our study cannot
prove this hypothesis, because cardiac output was not
measured in any study patient during the terminal phase.
Although no further differences in arterial blood pressures
at terminal cardiovascular collapse could be identified, our
analysis may have included too few patients to uncover
minor differences between other subgroups and some of
the observed variations between subgroups may have
equally resulted from small patient numbers in each
group.
Another interesting finding of this analysis is that pa-
tients receiving sedatives and/or opioids during the ter-
minal phase experienced terminal cardiovascular collapse
at significantly lower arterial blood pressures than patients
who were not exposed to such drugs. This observation
may have important practical implications because ter-
minal cardiovascular collapse in awake patients or patients
not exposed to sedative agents or opioids may occur at
relevantly higher arterial blood pressure levels (5 to
8 mmHg on average) than in sedated patients. Other
investigators have postulated that sedative agents and
opioids can reduce oxygen requirements and hence increase
the body’s tolerance to hypoxia and arterial hypotension
[24], as may have been the case in our cohort. These resultsare in accordance with data showing that a 1 mg/hr increase
of the benzodiazepine dose after withdrawal of life support
increased the time until death by 13 minutes [25]. Further
correlation analyses between arterial blood pressure at ter-
minal cardiovascular collapse and various other cofactors
did not reveal significant relationships. Several reasons may
account for this unexpected finding. First, 140 patients may
still have been too small a study population to detect
some correlations. Second, cofactors that were not in-
cluded in our correlation analysis may play a relevant
role. For example, it is likely that the individual
hemodynamic management and duration of preceding
arterial hypotension, particularly the time spent with
arterial blood pressures below the lower coronary
autoregulation threshold, may affect the arterial blood
pressure at terminal cardiovascular collapse.
When interpreting the results of this study, additional
limitations need to be noted. This was a retrospective
analysis and may thus contain methodological weak-
nesses such as missing values and heterogeneous data-
sets. A relevant selection bias may have been introduced
into the analysis in that 20.9% of patients who originally
met the inclusion criteria were excluded because their
arterial blood pressure at terminal cardiovascular col-
lapse could not be determined or because their terminal
cardiovascular collapse was caused by rhythmologic
pathologies. Although we failed to identify an arterial
blood pressure at which rhythmologic pathologies oc-
curred in patients excluded from this analysis (data not
shown), it is possible that such terminal rhythm distur-
bances might have been the consequence of coronary
hypoperfusion and that a delicate group of patients ex-
clusively sensitive to low arterial blood pressure levels
was excluded from our analysis.
Conclusions
The arterial blood pressure associated with terminal car-
diovascular collapse in critically ill patients was very low
and varied with individual comorbid conditions (for ex-
ample, congestive heart failure, left main stem stenosis,
severe valvular aortic stenosis, acute right heart failure),
drug exposure (for example, sedatives and/or opioids)
and the type of acute illness (for example, sepsis).
Key messages
 The arterial blood pressure associated with terminal
cardiovascular collapse in critically ill patients was
very low at 47 ± 12 mmHg systolic, 35 ± 11 mmHg
mean and 29 ± 9 mmHg diastolic arterial blood
pressure.
 Relevant exceptions were patients with congestive
heart failure, left main stem stenosis, severe valvular
aortic stenosis or acute right heart failure.
Brunauer et al. Critical Care  (2014) 18:719 Page 8 of 8 Sepsis patients and patients receiving sedatives and/
or opioids exhibited even lower arterial blood
pressures at terminal cardiovascular collapse.
Additional file
Additional file 1: Figure S1. Arterial lactate levels and critical MAP
values in patients stratified into different MAP levels at last lactate
measurement (242 ± 280 minutes before cardiovascular collapse).
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